Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: a meta-analysis of prospective cohorts

[1]  A. Thanopoulou,et al.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.

[2]  G. Moneta.  Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged Subjects , 2010 .

[3]  Thomas E. Moritz,et al.  Intensive glucose control and macrovascular outcomes in type 2 diabetes , 2009, Diabetologia.

[4]  T. Gill,et al.  Independent Association of HbA1c and Incident Cardiovascular Disease in People Without Diabetes , 2009, Obesity.

[5]  S. Sharp,et al.  Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events? , 2008, Archives of internal medicine.

[6]  B. Balkau.  The decode study , 2008 .

[7]  C. Brayne,et al.  An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: From a population based multi-centre longitudinal study , 2008, BMC public health.

[8]  P. Ridker,et al.  HbA1c Predicts Diabetes but not Cardiovascular Disease in Non- Diabetic Women , 2008 .

[9]  J. O’Keefe,et al.  Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. , 2007, The American journal of cardiology.

[10]  R. Klein,et al.  Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes. , 2007, American journal of epidemiology.

[11]  P. Ridker,et al.  Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. , 2007, The American journal of medicine.

[12]  D. Lawlor,et al.  Independent Associations of Fasting Insulin, Glucose, and Glycated Haemoglobin with Stroke and Coronary Heart Disease in Older Women , 2007, PLoS medicine.

[13]  D. Schuster,et al.  Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance. , 2007, European journal of endocrinology.

[14]  Nicholas J. Wareham,et al.  Glycated Hemoglobin and Risk of Stroke in People Without Known Diabetes in the European Prospective Investigation Into Cancer (EPIC)–Norfolk Prospective Population Study: A Threshold Relationship? , 2007, Stroke.

[15]  C. Murray,et al.  Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment , 2006, The Lancet.

[16]  G. Avalos,et al.  Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[17]  Peter Jüni,et al.  Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. , 2006, American heart journal.

[18]  A. Folsom,et al.  Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. , 2005, Archives of internal medicine.

[19]  J. Coresh,et al.  Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. , 2005, Diabetes care.

[20]  S. Yusuf,et al.  The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis , 2005, Diabetologia.

[21]  W. Mechelen,et al.  Epidemiological study air disaster in Amsterdam (ESADA): study design , 2005, BMC public health.

[22]  R. Sigal.  Haemoglobin A1c concentrations were associated with increased cardiovascular disease and all cause mortality , 2005 .

[23]  R. Sigal.  Hemoglobin A1c levels were associated with increased cardiovascular disease and all-cause mortality in persons with and without diabetes. , 2005, ACP journal club.

[24]  A. Ceriello.  Postprandial hyperglycemia and diabetes complications: is it time to treat? , 2005, Diabetes.

[25]  G Hu,et al.  Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study , 2004, Diabetologia.

[26]  M. Hanefeld,et al.  Postprandial glucose regulation and diabetic complications. , 2004, Archives of internal medicine.

[27]  P. Whelton,et al.  Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). , 2004, Annals of epidemiology.

[28]  N. Day,et al.  Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.

[29]  J. Meigs,et al.  Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. , 2004, Diabetes.

[30]  S. Humphries,et al.  What are the clinical manifestations of cardiovascular disease in diabetes? Ten year analysis from a clinic based population: , 2004 .

[31]  W. O’Neill,et al.  Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. , 2003, The American journal of cardiology.

[32]  Ralph B D'Agostino,et al.  Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. , 2002, Diabetes care.

[33]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[34]  M. Hanefeld,et al.  Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications. , 2002, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[35]  R. Holman,et al.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.

[36]  N. Wareham,et al.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) , 2001, BMJ : British Medical Journal.

[37]  S. Kahn,et al.  Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose. , 2001, Diabetes care.

[38]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[39]  L. Bouter,et al.  Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study , 1999, Diabetologia.

[40]  S. Yusuf,et al.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.

[41]  武井泉,et al.  United Kingdom Prospective Diabetes Study (UKPDS) , 1999 .

[42]  S. Lasker,et al.  Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. , 1998, Postgraduate medical journal.

[43]  J. Woo,et al.  Glycated haemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[44]  N. Black,et al.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.

[45]  R. Holman,et al.  Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.

[46]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[47]  S. Yusuf,et al.  Dysglycaemia and risk of cardiovascular disease , 1996, The Lancet.

[48]  E. Barrett-Connor,et al.  GHb Is a Better Predictor of Cardiovascular Disease Than Fasting or Postchallenge Plasma Glucose in Women Without Diabetes: The Rancho Bernardo Study , 1996, Diabetes Care.

[49]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[50]  D. Singer,et al.  Association of HbA1c With Prevalent Cardiovascular Disease in the Original Cohort of the Framingham Heart Study , 1992, Diabetes.

[51]  J. French,et al.  The Prognostic Value of Stress Hyperglycaemia and Previously Unrecognized Diabetes in Acute Stroke , 1987, Diabetic medicine : a journal of the British Diabetic Association.

[52]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .